Overview

Six Month Trial of Lamotrigine vs. Sodium Valproate for Treatment of Mixed Mania

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
We are comparing the efficacy of Lamotrigine to that of Standard of Care Sodium Valproate for the treatment of Mixed Mania. The study hypothesis is that Lamotrigine will be more efficative for treating mixed mania in patients with Bipolar Disorder.
Phase:
Phase 2
Details
Lead Sponsor:
Beth Israel Medical Center
Treatments:
Anticonvulsants
Lamotrigine
Valproic Acid